Tamer Saad Kaoud

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Assistant Professor

UAMS

Also affiliated: The Graduate Center, CUNY (2011); City College of New York (2011); The University of Texas MD Anderson Cancer Center (2012); King Abdulaziz University (2014); The University of Texas at Austin (2009–2025); Minia University (2013–2019)

33 h-index 137 pubs 2,387 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Tamer Saad Kaoud's research investigates molecular mechanisms underlying cancer development and progression, with a focus on signaling pathways and therapeutic targets. His work has explored the role of elongation factor 2 kinase in suppressing tumor growth and sensitizing breast cancers to chemotherapy, as well as the involvement of c-Jun N-terminal kinase (JNK) in promoting stem cell phenotypes in triple-negative breast cancer through Notch1 signaling. Kaoud has also contributed to understanding the function of arrestins as scaffolds in JNK signaling pathways, which are crucial for cellular responses to stress and other stimuli.

Beyond cancer research, Kaoud's publications indicate an interest in protein analysis and the characterization of viral components. He has investigated photodissociation techniques for peptide analysis and identified conserved epitopes on coronavirus spike proteins. His work also extends to the synthesis and evaluation of novel chemical compounds for potential anti-inflammatory and COX inhibitory activities.

With a career marked by 136 publications and 2,382 citations, Kaoud has an h-index of 33. His research activities are ongoing, with recent publications indicating continued engagement in the field.

Metrics

h-index: 33
Publications: 137
Citations: 2,387

Positions

Assistant Professor 2025–present

University of Arkansas for Medical Sciences College of Pharmacy ORCID
Research Assistant Professor 2020–2025

The University of Texas at Austin Pharmacy- Chemical Biology and Med. Chemistry ORCID

Selected Publications

Correction: Editorial: National Cancer Research Month 2025: Advances in Detection, Treatment and Therapies in Oncology (2026)

Frontiers in Oncology DOI OpenAlex
Editorial: National Cancer Research Month 2025: Advances in Detection, Treatment and Therapies in Oncology (2026)

Frontiers in Oncology DOI OpenAlex